Abiopharma

Hyperscale Data Issues Strategic Statement by Its Executive Chairman on Omnipresent Robotics and U.S. Based Robotics Infrastructure and Embodied AI Development

Oculis lýkur síðustu eftirfylgniheimsókn í fasa 3 DIAMOND rannsóknaráætluninni með OCS-01 augndropum til meðferðar á sjónhimnubjúg af völdum sykursýki

オムディア：2026年におけるAMOLEDスマートフォン用ディスプレイの出荷台数が大幅減となる見通し

Europe’s Technology Services Market Accelerates in Q1 on Higher Demand for AI: ISG Index™

Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema

Supplemental Update Regarding the Board’s Current Pricing Approach for Future M&A-Related Share Issuances

Europas Markt für Technologiedienstleistungen legt im ersten Quartal aufgrund der steigenden Nachfrage nach KI zu: ISG Index™

IQOS and Devialet Introduce “Soundsorial Design” Collaboration

SBC Medical onthult de prijs van de secundaire openbare aanbieding van 3,1 miljoen gewone aandelen

Il settore dei servizi tecnologici in Europa accelera nel T1 sulla spinta della maggiore richiesta di IA: ISG Index™